Occipital nerve stimulation for chronic migraine: A randomized trial on subthreshold stimulation. (January 2015)

• Record Type: Journal Article
• Authors: Slotty, PJ; Bara, G; Kowatz, L; Gendolla, A; Wille, C; Schu, S; Vesper, J
• Is Part Of: Cephalalgia. Volume 35:Number 1(2015)
• Page Start: 73
• Page End: 78
• Publication Date: 2015-01
• Subjects: Occipital nerve stimulation -- migraine -- primary headache disorders -- paresthesia -- randomized trial; Headache -- Periodicals; 616.8491
• DOI: 10.1177/0333102414534082
• Languages: English
• ISSNs: 0333-1024

Abstract

Introduction: Occipital nerve stimulation (ONS) may provide pain relief in migraine patients. In this double-blinded trial we investigated the significance of paresthesia and possible placebo effects. Methods: Patients already treated with ONS reporting stable treatment effect were included. "Effective stimulation, " "subthreshold stimulation" and "no stimulation" were compared. Patients cycled through all three treatment groups. Outcome was measured using the visual analog scale (VAS) for pain, McGill Pain Questionnaire and SF-36. Results: Eight patients were included, mean preoperative VAS was 8.20 ± 1.22. A significant improvement in pain was observed in favor of suprathreshold stimulation compared to subthreshold stimulation (1.98 ± 1.56 vs 5.65 ± 2.11). Pain also significantly improved under subthreshold stimulation compared to no stimulation (5.65 ± 2.11 vs 8.45 ± 0.99). No changes in SF-36 were observed. Conclusions: Paresthesia is not required to achieve pain reduction but suprathreshold stimulation yields better results, underlining the significance of stimulation parameter customization.